Robert A. Branch
Impact in
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Inflammatory mediators and NSAID effects
- Hepatology top 1%
- Liver Disease and Transplantation
Papers in
- Pharmacology 88
- Pharmacogenetics and Drug Metabolism 77
- Drug-Induced Hepatotoxicity and Protection 24
- Inflammatory mediators and NSAID effects 17
- Oncology 46
- Drug Transport and Resistance Mechanisms 35
- Co-authors
- G. Wilkinson (32 shared papers)David G. Shand (20 shared papers)Edwin K. Jackson (32 shared papers)John F. Gerkens (23 shared papers)Ramzi Sabra (20 shared papers)E Jacqz (9 shared papers)Alan S. Nies (14 shared papers)John A. Oates (5 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (39 papers)Journal of Pharmacology and Experimental Therapeutics (28 papers)Antimicrobial Agents and Chemotherapy (9 papers)Hepatology (8 papers)European Journal of Pharmacology (5 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Robert A. Branch
248 papers receiving 9.0k citations
Peers
Comparison fields: 5 of 165
- Pharmacology 3.3k
- Hepatology 878
- Pharmacology 1.6k
- Biochemistry 660
- Clinical Biochemistry 444
Countries citing papers authored by Robert A. Branch
This map shows the geographic impact of Robert A. Branch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Branch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Branch more than expected).
Fields of papers citing papers by Robert A. Branch
This network shows the impact of papers produced by Robert A. Branch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Branch. The network helps show where Robert A. Branch may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Branch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 371 | |
| 2 | 1988 | 367 | |
| 3 | 1988 | 297 | |
| 4 | 1989 | 239 | |
| 5 | 1984 | 230 | |
| 6 | 1997 | 194 | |
| 7 | 1990 | 189 | |
| 8 | 1982 | 185 | |
| 9 | 1973 | 152 | |
| 10 | 1979 | 150 | |
| 11 | 1988 | 147 | |
| 12 | 1989 | 146 | |
| 13 | 2010 | 143 | |
| 14 | 1978 | 138 | |
| 15 | 1978 | 129 | |
| 16 | 1981 | 122 | |
| 17 | 1983 | 121 | |
| 18 | 1978 | 118 | |
| 19 | 1974 | 115 | |
| 20 | 2007 | 113 |
About Robert A. Branch
Robert A. Branch is a scholar working on Pharmacology, Oncology, Pharmacology, Molecular Biology and Epidemiology, having authored 252 papers that have together received 9.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (77 papers), Drug Transport and Resistance Mechanisms (35 papers), Drug-Induced Hepatotoxicity and Protection (24 papers), Liver Disease Diagnosis and Treatment (20 papers), Eicosanoids and Hypertension Pharmacology (19 papers), Metabolism and Genetic Disorders (18 papers), Inflammatory mediators and NSAID effects (17 papers) and Liver Disease and Transplantation (17 papers). The work is most often cited by research in Pharmacology (3.3k citations), Hepatology (878 citations), Pharmacology (1.6k citations), Biochemistry (660 citations) and Clinical Biochemistry (444 citations). Robert A. Branch has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include G. Wilkinson, David G. Shand, Edwin K. Jackson, John F. Gerkens, Ramzi Sabra, E Jacqz, Alan S. Nies, John A. Oates, C B McAllister and Reginald F. Frye. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Pharmacology and Experimental Therapeutics, Antimicrobial Agents and Chemotherapy, Hepatology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.